文献速递消化、代谢与肾脏急症呼吸衰竭与机械通气

COVID-19患者急诊离院后的「假性安全」队列研究

Pseudo-safety in a cohort of patients with COVID-19 discharged home from the emergency department.
PubMed 文献 · Emerg Med J · 2021-02-18
一句话结论COVID-19患者急诊离院后2周内11.6%返回并住院,合并高血压、糖尿病、慢性肺病或发热者住院风险显著升高,属「假性安全」。

该回顾性多中心研究纳入2020年3月至8月美国多站点医疗系统急诊离院的COVID-19阳性患者923例,107例(11.6%)在2周内返回并住院。多变量分析显示,高血压、糖尿病、慢性肺病和发热分别使住院或重症风险增加1.92倍、2.20倍、2.21倍和2.89倍;具备至少两项上述风险因素者住院风险增加6.68倍。这些患者住院时间更长(中位5.92天 vs 3.21天,p<0.01),但ICU入住率和插管率无显著差异。作者认为,部分患者看似可安全居家,实则「假性安全」,尤其合并上述风险因素者。

要点

  • 急诊离院COVID-19患者中11.6%(107/923)在2周内返回并住院,提示离院后短期再入院风险不容忽视。
  • 多变量模型中,发热(OR 2.89,95%CI 1.71-4.82)、慢性肺病(OR 2.21,95%CI 1.22-3.92)、糖尿病(OR 2.20,95%CI 1.18-4.02)、高血压(OR 1.92,95%CI 1.07-3.41)均与住院风险独立相关。
  • 具备至少两项上述风险因素者,未来住院风险增加6.68倍(95%CI 3.54-12.70)。
  • 有高血压、糖尿病、慢性肺病或发热者住院时间显著更长(中位5.92天 vs 3.21天,p<0.01),ICU入住率(27.02% vs 14.30%,p=0.27)和插管率(12.16% vs 7.14%,p=0.71)数值更高但无统计学差异。
  • 仅使用不依赖实验室或影像的第一诊次数据,适合资源有限环境下的床旁评估。

适用人群与场景

  • 2020年3月至2020年8月在美国多站点医疗系统急诊就诊并离院的COVID-19阳性患者。
  • 分析限于首次就诊时不依赖实验室或影像诊断的数据,以适用于资源有限环境的床旁评估。

诊断标准与关键阈值

  • 具备至少两项风险因素(高血压、糖尿病、慢性肺病、发热)者未来住院风险增加6.68倍(95%CI 3.54-12.70)。

红旗征与不能漏的情况

  • 合并高血压、糖尿病、慢性肺病或发热的COVID-19患者,即使临床看似可居家,仍可能属于「假性安全」,有后续住院和更严重疾病风险。

研究设计与关键结果

  • 回顾性多中心研究,纳入923例急诊离院COVID-19阳性患者,107例(11.6%)在2周内返回并住院。
  • 多变量调整模型(n=788例有完整风险因素信息)中,高血压病史增加住院和重症风险1.92倍(95%CI 1.07-3.41),糖尿病2.20倍(95%CI 1.18-4.02),慢性肺病2.21倍(95%CI 1.22-3.92),发热2.89倍(95%CI 1.71-4.82)。
  • 具备至少两项上述风险因素者未来住院风险增加6.68倍(95%CI 3.54-12.70)。
  • 有高血压、糖尿病、慢性肺病或发热者住院时间显著更长(中位5.92天,3.08-10.95 vs 3.21,1.10-5.75,p<0.01),ICU入住率数值更高但无显著差异(27.02% vs 14.30%,p=0.27),插管率数值更高但无显著差异(12.16% vs 7.14%,p=0.71)。

证据类型、等级与局限

  • 证据类型:回顾性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对急诊离院的COVID-19患者,应关注高血压、糖尿病、慢性肺病和发热等风险因素,具备至少两项者后续住院风险显著升高,可能不宜简单视为可安全居家。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: EDs are often the first line of contact with individuals infected with COVID-19 and play a key role in triage. However, there is currently little specific guidance for deciding when patients with COVID-19 require hospitalisation and when they may be safely observed as an outpatient.

METHODS: In this retrospective study, we characterised all patients with COVID-19 discharged home from EDs in our US multisite healthcare system from March 2020 to August 2020, focusing on individuals who returned within 2 weeks and required hospital admission. We restricted analyses to first-encounter data that do not depend on laboratory or imaging diagnostics in order to inform point-of-care assessments in resource-limited environments. Vitals and comorbidities were extracted from the electronic health record. We performed ordinal logistic regression analyses to identify predictors of inpatient admission, intensive care and intubation.

RESULTS: Of n=923 patients who were COVID-19 positive discharged from the ED, n=107 (11.6%) returned within 2 weeks and were admitted. In a multivariable-adjusted model including n=788 patients with complete risk factor information, history of hypertension increased odds of hospitalisation and severe illness by 1.92-fold (95% CI 1.07 to 3.41), diabetes by 2.20-fold (1.18 to 4.02), chronic lung disease by 2.21-fold (1.22 to 3.92) and fever by 2.89-fold (1.71 to 4.82). Having at least two of these risk factors increased the odds of future hospitalisation by 6.68-fold (3.54 to 12.70). Patients with hypertension, diabetes, chronic lung disease or fever had significantly longer hospital stays (median 5.92 days, 3.08-10.95 vs 3.21, 1.10-5.75, p<0.01) with numerically higher but not significantly different rates of intensive care unit admission (27.02% vs 14.30%, p=0.27) and intubation (12.16% vs 7.14%, p=0.71).

DISCUSSION: Patients infected with COVID-19 may appear clinically safe for home convalescence. However, those with hypertension, diabetes, chronic lung disease and fever may in fact be only 'pseudo-safe' and are most at risk for subsequent hospitalisation with more severe illness and longer hospital stays.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Yuan N, Ji H, Sun N, et al. Pseudo-safety in a cohort of patients with COVID-19 discharged home from the emergency department. Emerg Med J. 2021. PMID: 33602725. doi:10.1136/emermed-2020-210041

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。